Keyphrases

1. Turkey 100%
2. Phospholipase 45%
3. Chronic Hepatitis C 39%
4. Platelets 38%
5. Malnutrition 32%
6. Capecitabine 32%
7. Collagen 31%
8. Renal Anemia 30%
9. Cerebral Palsy children 30%
10. Group Studies 30%
11. Insulin Resistance 30%
12. Human Epidermal Growth Factor Receptor 2 (HER2) 30%
13. Oncology 30%
14. Platelet Aggregation 25%
15. Evaluation Period 22%
16. Efficacy Evaluation 22%
17. Hepatic Fibrosis 22%
18. Micronutrients 20%
19. Receptor Activation 20%
20. Non-interventional 19%
21. Breast Cancer Patients 18%
22. Clinical Trials 18%
23. Clinical Research 18%
24. Confidence Interval 18%
25. Phospholipase C gamma 2 18%
26. COVID-19 Pandemic 18%
27. Oxaliplatin 17%
28. Hemoglobin 17%
29. Carboxyl 17%
30. Bisphosphonates 16%
31. Anthropometric Measurements 16%
32. Odds Ratio 16%
33. Terminal Sequence 15%
34. Aripiprazole 15%
35. Receptor Gene 15%
36. Pharmacological Challenge 15%
37. Turkish Society 15%
38. Radiation Oncology 15%
39. Human Platelets 15%
40. 5-hydroxytryptamine 2A Receptor 15%
41. Treatment Adherence 15%
42. Gene Candidates 15%
43. T102C 15%
44. Serum Micronutrients 15%
45. Atopy 15%
46. Allergic Diseases 15%
47. Rotavirus Infection 15%
48. In Situ Hybridization 15%
49. HER2 Status 15%
50. Invasive Breast Carcinoma 15%